patented technology to grow and expand adult Stem Cells
Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

AGORACOM News Flash

AGORACOM WIRE - WEDNESDAY MAY 30TH, 2012

GOLDEN HOPE MINES (TSXV:GNH) Confirms High Grade Intersection of 64.1 g/t Au (Gold) over 1m Read More 

  • The screen metallic analysis returned 82 g/t Au for an average grade of 93.5 g/t Au.
  • Two additional fire assays on the original pulp done prior to the screen metallic analyses returned 0.22 g/t Au and 0.12 g/t Au for an average fire assay grade of 0.41 g/t Au. The weighted average of all the fire assays and screen metallic assays from this 1-metre section in hole BD2011-184 is 64.1 g/t Au.

Sonomax® eers™ Custom Earbuds Announces Sponsorship of MUTEK 2012

CONTINENTAL ENERGY  Geothermal Energy Project Receives US$ 11.5 Million Grant Read More * Client

AGORACOM Launches Graphite Stocks Blog

Top Stories

  • FOCUS METALS (TSXV:FMS) Changes Its Name to Focus Graphite Inc. Read More   |   *SPONSOR

  • LOMIKO METALS (TSXV:LMK) Paul Gill Discusses Exploration Initiative with James West of Midas Letter Read More   |   *SPONSOR
  • GRAPHITE DEMAND Seen Surging from Fuel Cells, Nuclear Reactors, Graphene Read More

 

 

Close

Due Dilligence

5-9-12, Pluristem's PLX Cells Saves the Life of a Child after Bone Marrow Transplantation Failure.

4-17-12, Pluristem Receives U.S. FDA Clearance for Phase II Clinical Trial for the treatment of peripheral artery disease (PAD).

Beosound_2
Posted by: emit on April 18, 2012 08:12PM
URL: http://www.pluristem.com/index.php?optio...ticle&id=223:-april-6&catid=4&Itemid=104

Pluristem Life Systems, Inc. Links

5-9-12, Pluristem's PLX Cells Saves the Life of a Child after Bone Marrow Transplantation Failure.

4-17-12, Pluristem Receives U.S. FDA Clearance for Phase II Clinical Trial for the treatment of peripheral artery disease (PAD).

Beosound_2
Posted by: emit on April 18, 2012 08:12PM
URL: http://www.pluristem.com/index.php?optio...ticle&id=223:-april-6&catid=4&Itemid=104

Pluristem and United Therapeutics Enter into an Exclusive License Agreement to Develop and Commercialize PLX Cells for the Treatment of Pulmonary Hypertension.

United Therapeutics will make an upfront payment of $7 million to Pluristem; and other payments accumulating together with the upfront payment to a total of approximately $55 million.

Beosound_2
Posted by: emit on July 11, 2011 01:47PM
URL: http://www.pluristem.com/index.php?optio...ticle&id=174:-april-6&catid=4&Itemid=104

3-1-11, Positive Pre-Clinical Data From Muscle Injury Study Moves Pluristem Toward Second Multi-Billion Dollar Clinical Indication.

Beosound_2
Posted by: emit on March 10, 2011 07:36PM
URL: http://app.quotemedia.com/quotetools/new...symbology=null&cp=null&webmasterId=92583

The PluriX™ Bioreactor

System is designed to creates an artificial physiological environment where cells (ASCs) can grow and reproduce outside of the human body. By mimicking the natural environment that exists within human bones, the system “tricks” stem cells into growing and reproducing in the same way they would in living organs. Because the size and scale of the PluriX™ Bioreactor is larger than that of human bone marrow, stem cell growth can be greatly expanded.

Beosound_2
Posted by: emit on January 25, 2011 03:19PM
URL: http://www.pluristem.com/Pluristem_tech.asp

1-18-11, Pluristem on Track to Proceed to a Phase II/III Clinical Trial in Critical Limb Ischemia (CLI) Under a Joint FDA-EMA Protocol, and a Phase II Clinical Trial in Intermittent Claudication (IC)

Beosound_2
Posted by: emit on January 18, 2011 02:42PM
URL: http://finance.yahoo.com/news/Pluristem-...k-to-Proceed-pz-3092433445.html?x=0&.v=1

Data from Clinical Trials Show Pluristem's Placenta-Derived Cell Therapy is Safe and Improves Quality of Life and Efficacy Measurements in Patients With Critical Limb Ischemia

“The results of these trials provide a strong indication of the potential success of commercializing PLX-PAD,” said Zami Aberman, President, Chairman and CEO of Pluristem

Beosound_2
Posted by: emit on September 14, 2010 04:06PM
URL: http://agoracom.com/ir/pluristem/forums/...oves-quality-of/messages/1439122#message

6-28-10, Pluristem is Advancing Toward Two Phase IIb Clinical Trials for Treatment of Critical Limb Ischemia and Moderate-Severe Claudication.

Company Awarded a $2.5 Million Grant from Israeli Government.

Beosound_2
Posted by: emit on June 29, 2010 07:37PM
URL: http://finance.yahoo.com/news/Pluristem-...ncing-Toward-bw-2001885003.html?x=0&.v=1

5-20-10, Pluristem’s Off-The-Shelf Placenta-Derived Cell Therapies - The Focus of Presentations at Upcoming Investor and Medical Conferences

Chaya Mazouz, the company’s vice president of clinical and regulatory affairs, will present information about the regulatory study design considerations for PLX-PAD, the company’s lead cell therapy candidate for the treatment of critical limb ischemia (CLI), at 11 a.m. EDT on May 24 at the International Society for Cellular Therapy’s (ISCT) 16th Annual Meeting in Philadelphia

Beosound_2
Posted by: emit on June 09, 2010 02:35PM
URL: http://www.pluristem.com/20_05_2010-a.asp

11-17-09, Pluristem Therapeutics Announces Three Month Follow-Up Data from the First Patient to Receive PLX-PAD.

Data Suggests PLX-PAD is Safe, with Noted Improvement in Measured Efficacy Parameters.

Beosound_2
Posted by: emit on December 23, 2009 07:02PM
URL: http://agoracom.com/ir/pluristem/forums/...ceiving-plx-pad/messages/1267475#message

9-10-09, Pluristem Begins Enrollment in U.S. in a Phase I Clinical Trial for Treatment of Peripheral Artery Disease.

It has begun enrolling patients in the U.S. for a Phase I clinical trial with its unmatched placenta-derived stem cell product, PLX-PAD for the treatment of critical limb ischemia, of (PAD).

Beosound_2
Posted by: emit on October 13, 2009 07:48PM
URL: http://app.quotemedia.com/quotetools/new...symbology=null&cp=null&webmasterId=92583

AGORACOM Quick Tips

Recent Drill Results: 63m of 1.21 g\t gold and 2m of 13.95 g/t gold ... Learn More!
Watch
Today's Show
in 00:00:000

President's D.D.

5-9-12, Pluristem's PLX Cells Saves the Life of a Child after Bone Marrow Transplantation Failure.
4-17-12, Pluristem Receives U.S. FDA Clearance for Phase II Clinical Trial for the treatment of peripheral artery disease (PAD). read more
Beosound_2
Posted by: emit
On: April 18, 2012
URL: http://www.p...4&Itemid=104

Stock Quote

Open PSTI Stock Quote

Investment Ideas

Like Pluristem Life Systems, Inc.? Then you might also be interested in Star Navigation Systems Group Ltd.

Star Navigation Systems Group Ltd.
  • Developer of the TERRASTARTM in-flight safety monitoring system
  • The first system in the world to feature real-time in-flight data monitoring and diagnostics
  • echnical Partnership Agreement with Astrium, a wholly owned subsidiary of EADS

Hub Leaders

Beosound_2
emit
Generic_tiny
emma
Dsc_0077
EDIGOKIE